MY
Mainz Biomed B.V.
MYNZ · NASDAQ
$0.70 -5.07% (-$0.04)
Piotroski F-Score Moderate
4/9Valuation
-
N/A PEG N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
29 /100
Unstable Beta 0.32x
EPS volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MYNZ
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Guido Baechler
Employees
19
Headquarters
Mainz